TY  - GEN
AU  - Sancho-López, Aránzazu
AU  - Caballero-Bermejo, Antonio F
AU  - Ruiz-Antoran, Belen
AU  - Munez Rubio, Elena
AU  - García-Gasalla, Mercedes
AU  - Bonilla, Alfonso
AU  - Gonzalez Rozas, Marta
AU  - Lopez Veloso, Maria
AU  - Muñoz Gomez, Ana
AU  - Cuenca Abarca, Ana
AU  - Duran del Campo, Pedro
AU  - Ibanez, Fatima
AU  - Diaz de Santiago, Alberto
AU  - Romero, Yolanda
AU  - Calderon, Jorge
AU  - Pintos, Ilduara
AU  - Ferré Beltrán, Adrián
AU  - Centeno Soto, Gustavo
AU  - Campos, Jose
AU  - Ramos Martinez, Antonio
AU  - Avendano-Sola, Cristina
AU  - Fernandez Cruz, Ana
AU  - SARTRE-Study Group
PY  - 2021
DO  - 10.1007/s40121-021-00543-2
SN  - 2193-8229
UR  - https://hdl.handle.net/20.500.12105/23345
AB  - Introduction: SARS-CoV-2 pneumonia is often associated with hyper-inflammation. The cytokine-storm-like is one of the targets of current therapies for coronavirus disease 2019 (COVID-19). High Interleukin-6 (IL6) blood levels have been identified in...
LA  - eng
PB  - Springer
KW  - Corticosteroids
KW  - COVID19
KW  - IL6-inhibitors
KW  - Randomized clinical trial
KW  - Sarilumab
TI  - Efficacy and Safety of Sarilumab in patients with COVID19 Pneumonia: A Randomized, Phase III Clinical Trial (SARTRE Study)
TY  - research article
ER  -